Rare disease specialist Shire ($SHPG) announced today that it has received Fast Track Designation from the FDA for a reformulated, intrathecally delivered version of ...
TipRanks on MSN
Taysha Gene Therapies announces progress across TSHA-102
Taysha Gene Therapies (TSHA) announced progress across the TSHA-102 pivotal program, an intrathecally delivered AAV9 gene therapy with disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback